Coffee and Parkinson's Disease; Undiagnosed Dementia and Finances; ALS Trial Data

— News and commentary from the world of neurology and neuroscience

Neuro Break over a computer rendering of neurons.

Early Parkinson's patients with had 8% to 15% lower dopamine transporter binding compared with low coffee drinkers, but no significant effects on symptoms, including motor function, were seen. (Annals of Neurology)

Lewy body dementia showed distinct changes in compared with Alzheimer's disease, an analysis of voice data showed. (Alzheimer's & Dementia)

One in eight older Americans was during an 18-year study period. (JAMA Network Open)

Neurofilament light is inching its way toward as a biomarker of frontotemporal degeneration, the Foundation for the National Institutes of Health reported.

Undiagnosed memory disorders can create and credit outcomes, according to a Federal Reserve Bank of New York report.

Astrocytic signaling may have in females and males. (Cell Reports)

Here's how humans distinguish . (PLOS Biology)

People were likely to of neurodegenerative diseases due to their relationship with clinical staff, a meta-analysis showed. (Neurology)

New trials investigated the use of (Rystiggo) and in chronic inflammatory demyelinating polyneuropathy (CIDP). (Journal of Neurology, Neurosurgery, and Psychiatry)

Investigational , a heat-shock protein-70 (HSP70) co-inducer, did not improve efficacy outcomes in a phase III amyotrophic lateral sclerosis (ALS) trial. (Lancet Neurology)

  • Judy George covers neurology and neuroscience news for app, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more.